Skip Navigation



Human Molecular Genetics Advance Access published online on October 4, 2007

Human Molecular Genetics, doi:10.1093/hmg/ddm290
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
17/1/130    most recent
ddm290v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Subramanian, V.
Right arrow Articles by Acharya, K. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Subramanian, V.
Right arrow Articles by Acharya, K. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Human angiogenin is a neuroprotective factor and Amyotrophic Lateral Sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of motor neurons

Vasanta Subramanian*, Benedict Crabtree and K. Ravi Acharya

Department of Biology and Biochemistry, University of Bath, Bath BA2 7AY, United Kingdom

* To whom correspondence should be addressed at: Department of Biology and Biochemistry, Building 4 South, University of Bath, Claverton Down, Bath BA2 7AY, U.K. Tel: +44 1225 386315; Fax: +44 1225 386779; E-mail bssvss{at}bath.ac.uk

Received August 14, 2007; Revised September 30, 2007; Accepted September 30, 2007

Amyotrophic Lateral Sclerosis (ALS) is a late onset neurodegenerative disorder affecting upper and lower motor neurons (MNs). The molecular mechanisms underlying ALS are poorly understood. Mutations in SOD1 is one of the known causes of ALS but occur only in a very small number of cases of ALS. Interestingly, mutations in human angiogenin (hANG), a member of the ribonuclease A (RNase A) superfamily known to be involved in neovascularization, have been recently reported in patients with ALS but the effects of these mutations on MN differentiation and survival has not been investigated. We have used the well characterized pluripotent P19 embryonal carcinoma (EC) cell culture model of neuro-ectodermal differentiation to study the effects of hANG-ALS variants on MN differentiation and survival. Here we report that P19 EC cells induced to differentiate in the presence of hANG and hANG-ALS associated variants internalize the wild type and variant proteins. The P19 EC cells differentiate to form neurons but the ability of the neurites to extend and make contacts with neighbouring neurites is compromised when treated with the hANG-ALS variants. In addition, hANG-ALS variants also have a cytotoxic effect on MNs leading to their degeneration. hANG was able to protect neurons from hypoxia induced cell death but the variants of hANG implicated in ALS lacked the neuroprotective activity. Our findings show that ANG plays an important role in neurite extension/pathfinding and survival providing a causal link between mutations in hANG and ALS.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
M. Kulka, N. Fukuishi, and D. D. Metcalfe
Human mast cells synthesize and release angiogenin, a member of the ribonuclease A (RNase A) superfamily
J. Leukoc. Biol., November 1, 2009; 86(5): 1217 - 1226.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.